Go back

Covid drives surge in requests for EMA science advice

Image: European Commission 2020

European Medicines Agency sees requests for help rise by a fifth but licence applications decrease

The European Medicines Agency saw a 20 per cent increase in requests for scientific advice from medicines developers in the first half of 2021 compared with the previous year, driven by the Covid-19 pandemic.

The regulator also reported that over the same period, the number of applications for drug licences dropped compared with 2020.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.